Eporgen - Nurturing the winners
Description
pulled from site's meta descriptionEporgen is the first Italian company, entirely funded by private, non-institutional investors, which is dedicated to seed capital investments in the area of life sciences.
This is an automatically generated AboutUs page for Eporgen.it. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- Eporgen
- portfolio
- start-up
- patents
- bio
- financing
- pharma
- research
- academic institutions
- proof-of-concept
- candiolo
- tumour
- peptides
- hepatic tumors
- endometriosis
- anti-cancer
- drug
- Hepatoma Derived Growth Factors
- HDGF
- vaccines
- chronic diseases
- renal
- prostate
- lupus
- glycobiology
- D-Glucuronyl C-5 Epimerase
- equine milk
- neonatal infections
- rotavirus
- lipopeptides
- antibiotic
- gram-negative
- antiviral
- melusin
- heart
- eco-compatible antifouling biorepellent
- boats
- ships
- electroporation
- transgenic
- markers
- autoimmune disorders
- sclerosis
- dental ailments
- caries
- salivary
- seed capital investments
- life sciences
- APAvadis
- BioNucleon
- Genovax
- Glyconova
- RotaLactis
- Spider Biotech
- Target Heart Biotec
- Bioindustry Park
- Canavese
- Fumero
- Biopaint
- Narvalus
- NoToPharm
- Smile Biotech